endopredict ep Search Results


endopredict (ep) sividon  (Sividon Diagnostics GmbH)
90
Sividon Diagnostics GmbH endopredict (ep) sividon
Endopredict (Ep) Sividon, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endopredict (ep) sividon/product/Sividon Diagnostics GmbH
Average 90 stars, based on 1 article reviews
endopredict (ep) sividon - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
endopredict (ep)  (Myriad Genetics)
90
Myriad Genetics endopredict (ep)
Relationship of the Recurrence Score (RS), Risk of Recurrence (ROR), <t>EndoPredict</t> (EP), and Breast Cancer Index (BCI) molecular scores with clinical characteristics. Number of positive nodes > 10 was set to 10 in this figure. Spearman’s ρ correlation coefficients are presented. Tumor sizes > 50 mm were set to 50 in this figure. Int, intermediate.
Endopredict (Ep), supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endopredict (ep)/product/Myriad Genetics
Average 90 stars, based on 1 article reviews
endopredict (ep) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
endopredict® (12-ep)  (Sividon Diagnostics GmbH)
90
Sividon Diagnostics GmbH endopredict® (12-ep)
Relationship of the Recurrence Score (RS), Risk of Recurrence (ROR), <t>EndoPredict</t> (EP), and Breast Cancer Index (BCI) molecular scores with clinical characteristics. Number of positive nodes > 10 was set to 10 in this figure. Spearman’s ρ correlation coefficients are presented. Tumor sizes > 50 mm were set to 50 in this figure. Int, intermediate.
Endopredict® (12 Ep), supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endopredict® (12-ep)/product/Sividon Diagnostics GmbH
Average 90 stars, based on 1 article reviews
endopredict® (12-ep) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Relationship of the Recurrence Score (RS), Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) molecular scores with clinical characteristics. Number of positive nodes > 10 was set to 10 in this figure. Spearman’s ρ correlation coefficients are presented. Tumor sizes > 50 mm were set to 50 in this figure. Int, intermediate.

Journal: Journal of Clinical Oncology

Article Title: Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

doi: 10.1200/JCO.20.00853

Figure Lengend Snippet: Relationship of the Recurrence Score (RS), Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) molecular scores with clinical characteristics. Number of positive nodes > 10 was set to 10 in this figure. Spearman’s ρ correlation coefficients are presented. Tumor sizes > 50 mm were set to 50 in this figure. Int, intermediate.

Article Snippet: Other tests include the Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR) score (Prosigna; NanoString Technologies, Seattle, WA), EndoPredict (EP; Myriad Genetics, Cologne, Germany), Breast Cancer Index (BCI; Biotheranostics, San Diego, CA), and MammaPrint (Agendia, Amsterdam, the Netherlands) that measure 46, 8, 7, and 70 genes, respectively, to characterize tumor biology in addition to reference genes.

Techniques:

Scatter plots and Spearman’s ρ correlation coefficients of the Recurrence Score (RS), Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) molecular scores in TransATAC.

Journal: Journal of Clinical Oncology

Article Title: Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

doi: 10.1200/JCO.20.00853

Figure Lengend Snippet: Scatter plots and Spearman’s ρ correlation coefficients of the Recurrence Score (RS), Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) molecular scores in TransATAC.

Article Snippet: Other tests include the Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR) score (Prosigna; NanoString Technologies, Seattle, WA), EndoPredict (EP; Myriad Genetics, Cologne, Germany), Breast Cancer Index (BCI; Biotheranostics, San Diego, CA), and MammaPrint (Agendia, Amsterdam, the Netherlands) that measure 46, 8, 7, and 70 genes, respectively, to characterize tumor biology in addition to reference genes.

Techniques:

Associations of the (A) Risk of Recurrence (ROR), (B) EndoPredict (EP), and (C) Breast Cancer Index (BCI) with the proliferation, estrogen, human epidermal growth factor receptor 2 (HER2), and invasion modules of the Recurrence Score (RS). Spearman’s ρ correlation coefficients are presented.

Journal: Journal of Clinical Oncology

Article Title: Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

doi: 10.1200/JCO.20.00853

Figure Lengend Snippet: Associations of the (A) Risk of Recurrence (ROR), (B) EndoPredict (EP), and (C) Breast Cancer Index (BCI) with the proliferation, estrogen, human epidermal growth factor receptor 2 (HER2), and invasion modules of the Recurrence Score (RS). Spearman’s ρ correlation coefficients are presented.

Article Snippet: Other tests include the Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR) score (Prosigna; NanoString Technologies, Seattle, WA), EndoPredict (EP; Myriad Genetics, Cologne, Germany), Breast Cancer Index (BCI; Biotheranostics, San Diego, CA), and MammaPrint (Agendia, Amsterdam, the Netherlands) that measure 46, 8, 7, and 70 genes, respectively, to characterize tumor biology in addition to reference genes.

Techniques: